# MR-based Collateral Imaging to Predict Response to Endovascular Treatment of Stroke (FAST-COLL Study)

> **NCT02668627** · — · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 120 (estimated)

## Conditions studied

- Stroke

## Interventions

- **PROCEDURE:** Endovascular treatment

## Key facts

- **NCT ID:** NCT02668627
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-12
- **Primary completion:** 2017-12
- **Final completion:** 2018-05
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2017-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02668627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02668627, "MR-based Collateral Imaging to Predict Response to Endovascular Treatment of Stroke (FAST-COLL Study)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02668627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*